Development of A Novel Magnetic Exosomal Assay for Diagnosis of Diseases with Impaired Vascular Integrity

Information

  • Research Project
  • 9410664
  • ApplicationId
    9410664
  • Core Project Number
    R43HL131207
  • Full Project Number
    3R43HL131207-01A1S1
  • Serial Number
    131207
  • FOA Number
    PA-16-414
  • Sub Project Id
  • Project Start Date
    3/15/2017 - 7 years ago
  • Project End Date
    6/30/2017 - 7 years ago
  • Program Officer Name
    DANTHI, NARASIMHAN
  • Budget Start Date
    3/15/2017 - 7 years ago
  • Budget End Date
    6/30/2017 - 7 years ago
  • Fiscal Year
    2017
  • Support Year
    01
  • Suffix
    A1S1
  • Award Notice Date
    3/1/2017 - 7 years ago
Organizations

Development of A Novel Magnetic Exosomal Assay for Diagnosis of Diseases with Impaired Vascular Integrity

? DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase 1 project aims to develop and characterize a novel Magnetic Exosomal Assay to isolate and detect single intact exosome concentrations in human serum. This proposed research will also evaluate the diagnostic potential of the Magnetic Exosomal Assay for diseases with impaired vascular integrity. Vascular integrity or the maintenance of blood vessel continuity is a fundamental process maintained through endothelial cell-cell junctions. Defects in endothelial barrier function are an initiating factor in several disease processes including atherosclerosis, ischemia/reperfusion, tumor angiogenesis, cancer metastasis, diabetes, sepsis and acute lung injury. An initial event in impaired vascular integrity is a dramatic increase in a novel type of extracellular vesicle (EV) from endothelial cells (EC) called exosomes. Therefore, the development of a highly sensitive, reproducible and easy-to- implement assay to detect exosome concentrations in complex clinical samples can have potential diagnostic and therapeutic benefit. In this research proposal, we will develop and characterize a novel Magnetic Exosomal Assay kit and reader for fast isolation and detection of single intact exosome concentrations in human serum. In addition, we will assess the optimized Magnetic Exosomal Assay on Community-Acquired Pneumonia patient serum. The ultimate goal of this research is to develop a highly sensitive, reproducible and easy to implement exosomal assay as a diagnostic tool for patients with various types of impaired vascular integrity-related diseases.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    3
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    50000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:50000\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
  • Study Section Name
  • Organization Name
    MICROSENSOR LABS, LLC
  • Organization Department
  • Organization DUNS
    078821463
  • Organization City
    CHICAGO
  • Organization State
    IL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    606372002
  • Organization District
    UNITED STATES